Italy · Biotechnology
Italy · BiotechnologyAAVantgarde Bio
AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
PrivateFor profit
Against its peers
Set against 208 Biotechnology companies in Italy. The ring marks the typical peer.
Across all 5.9M companies: larger than 0% of those with a size listed; older than 0% of those with a founding year; website ranked #4,703,899 in the world, about 2k visits a month.
About AAVantgarde Bio
BiotechnologyHealth CareTherapeutics
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$141M
raised in total, currency not stated across 2 rounds
Last raised Jun 2023, 3 years ago
- Rounds
- 2
- Latest round
- Series a
- Investors
- 53 leading
Key facts
Who started it and how it trades.
- Founded by
- Alberto Auricchio
Every detail we hold
Everything the source datasets list about AAVantgarde Bio, field by field. Contact details are held but never shown.
The company7 fields
- Name
- AAVantgarde Bio
- Type
- For profit
- Status
- Private
- Founded
- 2021
- Founders
- Alberto Auricchio
- Industry
- Biotechnology
- Categories
- Biotechnology, Health Care, Therapeutics
Where3 fields
- City
- Milano
- Country
- Italy
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach3 fields
- Staff band
- 1-10
- Web traffic rank
- #4,703,899
- Monthly web visits
- 1,969
Show 9 more fieldsShow fewer fields
Funding, as listed7 fields
- Total
- 141,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series a
- Latest round date
- Jun 2023
- Investors
- 5
- Lead investors
- 3
- Listing status
- private
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
AAVantgarde Bio may be growing as the company operates in the biotechnology and therapeutics industry, specifically focusing on gene therapies for inherited retinal disorders. The Usher Syndrome market, which is closely related to their field of work, is projected to grow at a CAGR of 10.55% by 2034. This indicates a growing demand for treatments in the sector where AAVantgarde Bio is developing its products. The expansion of the market suggests a positive environment for the company's growth prospects.
Companies like AAVantgarde Bio
Biotechnology in Italy.
SACCO S.R.L.Cadorago · 251-500 peoplefounded 87 years earlierCentro Sperimentale del Latte S.r.l.Zelo Buon Persicofounded 73 years earlierSaccoCapolago · 251-500 peoplefounded 87 years earlier
CoStim Pharmaceuticals11-50 peoplefounded 10 years earlierMMolMedMilano · 101-250 peoplefounded 25 years earlierBuild a lead list
208 Biotechnology companies in Italy, filtered by size, age and reach, ready to export with emails on Pro.